Alpha-Synuclein Seed Amplification Assays in Parkinson’s Disease: A Systematic Review and Network Meta-Analysis

Introduction and objective: Assessment of α-synuclein (αSyn) seed amplification assays (αSyn-SAA) accuracy in distinguishing Parkinson’s disease (PD) from controls using cerebrospinal fluid (CSF), blood, skin, extracellular vesicles (ECV), saliva, olfactory mucosa (OM), gastrointestinal tract (GIT),...

Full description

Saved in:
Bibliographic Details
Main Authors: Jamir Pitton Rissardo, Ana Leticia Fornari Caprara
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Clinics and Practice
Subjects:
Online Access:https://www.mdpi.com/2039-7283/15/6/107
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839654377175908352
author Jamir Pitton Rissardo
Ana Leticia Fornari Caprara
author_facet Jamir Pitton Rissardo
Ana Leticia Fornari Caprara
author_sort Jamir Pitton Rissardo
collection DOAJ
description Introduction and objective: Assessment of α-synuclein (αSyn) seed amplification assays (αSyn-SAA) accuracy in distinguishing Parkinson’s disease (PD) from controls using cerebrospinal fluid (CSF), blood, skin, extracellular vesicles (ECV), saliva, olfactory mucosa (OM), gastrointestinal tract (GIT), and submandibular gland (SMG). Methodology: PubMed was searched for articles from 2010 to January 2025. The quality assessment used robvis. Diagnostic values with a 95% confidence interval (CI) were obtained. Z-test, Wald CI, and ANOVA were performed. Diagnostic odds ratio (DOR) was used. Results: αSyn-SAAs showed strong diagnostic performance in distinguishing PD from controls across various tissue and fluid types. Overall, αSyn-SAAs demonstrated high sensitivity (86%) and specificity (92%). Among all biomatrices, CSF, skin, blood, and ECV yielded the highest diagnostic accuracy, with sensitivity and specificity approaching or exceeding 90%. In contrast, saliva, oral mucosa, and gastrointestinal tract samples showed more modest sensitivity, though specificity remained relatively high. ECV, CSF, skin, and blood matrices also demonstrated the highest DOR, supporting their potential clinical utility. Conclusions: ECV and blood warrant priority in αSyn-SAA for high accuracy and minimal invasiveness, while GIT, OM, and oral samples show limited utility; saliva and SMG need refinement.
format Article
id doaj-art-08e611e6e16147e590c20bfd1c1c17d7
institution Matheson Library
issn 2039-7283
language English
publishDate 2025-06-01
publisher MDPI AG
record_format Article
series Clinics and Practice
spelling doaj-art-08e611e6e16147e590c20bfd1c1c17d72025-06-25T13:39:09ZengMDPI AGClinics and Practice2039-72832025-06-0115610710.3390/clinpract15060107Alpha-Synuclein Seed Amplification Assays in Parkinson’s Disease: A Systematic Review and Network Meta-AnalysisJamir Pitton Rissardo0Ana Leticia Fornari Caprara1Neurology Department, Cooper University Hospital, Camden, NJ 08103, USANeurology Department, Cooper University Hospital, Camden, NJ 08103, USAIntroduction and objective: Assessment of α-synuclein (αSyn) seed amplification assays (αSyn-SAA) accuracy in distinguishing Parkinson’s disease (PD) from controls using cerebrospinal fluid (CSF), blood, skin, extracellular vesicles (ECV), saliva, olfactory mucosa (OM), gastrointestinal tract (GIT), and submandibular gland (SMG). Methodology: PubMed was searched for articles from 2010 to January 2025. The quality assessment used robvis. Diagnostic values with a 95% confidence interval (CI) were obtained. Z-test, Wald CI, and ANOVA were performed. Diagnostic odds ratio (DOR) was used. Results: αSyn-SAAs showed strong diagnostic performance in distinguishing PD from controls across various tissue and fluid types. Overall, αSyn-SAAs demonstrated high sensitivity (86%) and specificity (92%). Among all biomatrices, CSF, skin, blood, and ECV yielded the highest diagnostic accuracy, with sensitivity and specificity approaching or exceeding 90%. In contrast, saliva, oral mucosa, and gastrointestinal tract samples showed more modest sensitivity, though specificity remained relatively high. ECV, CSF, skin, and blood matrices also demonstrated the highest DOR, supporting their potential clinical utility. Conclusions: ECV and blood warrant priority in αSyn-SAA for high accuracy and minimal invasiveness, while GIT, OM, and oral samples show limited utility; saliva and SMG need refinement.https://www.mdpi.com/2039-7283/15/6/107alpha-synucleinsynucleinopathybiomarkerbiofluidprotein misfolding cyclic amplification (PMCA)real-time quaking-induced conversion (RT-QuIC)
spellingShingle Jamir Pitton Rissardo
Ana Leticia Fornari Caprara
Alpha-Synuclein Seed Amplification Assays in Parkinson’s Disease: A Systematic Review and Network Meta-Analysis
Clinics and Practice
alpha-synuclein
synucleinopathy
biomarker
biofluid
protein misfolding cyclic amplification (PMCA)
real-time quaking-induced conversion (RT-QuIC)
title Alpha-Synuclein Seed Amplification Assays in Parkinson’s Disease: A Systematic Review and Network Meta-Analysis
title_full Alpha-Synuclein Seed Amplification Assays in Parkinson’s Disease: A Systematic Review and Network Meta-Analysis
title_fullStr Alpha-Synuclein Seed Amplification Assays in Parkinson’s Disease: A Systematic Review and Network Meta-Analysis
title_full_unstemmed Alpha-Synuclein Seed Amplification Assays in Parkinson’s Disease: A Systematic Review and Network Meta-Analysis
title_short Alpha-Synuclein Seed Amplification Assays in Parkinson’s Disease: A Systematic Review and Network Meta-Analysis
title_sort alpha synuclein seed amplification assays in parkinson s disease a systematic review and network meta analysis
topic alpha-synuclein
synucleinopathy
biomarker
biofluid
protein misfolding cyclic amplification (PMCA)
real-time quaking-induced conversion (RT-QuIC)
url https://www.mdpi.com/2039-7283/15/6/107
work_keys_str_mv AT jamirpittonrissardo alphasynucleinseedamplificationassaysinparkinsonsdiseaseasystematicreviewandnetworkmetaanalysis
AT analeticiafornaricaprara alphasynucleinseedamplificationassaysinparkinsonsdiseaseasystematicreviewandnetworkmetaanalysis